-
Je něco špatně v tomto záznamu ?
Deciphering Aspergillus section Terrei in Galleria mellonella model: a clade-specific pathogenicity characterization
R. Vahedi-Shahandashti, J. Houbraken, V. Hubka, M. Meijer, BG. Zelger, U. Binder, C. Lass-Flörl
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
W1253-B24
Doctoral Program HOROS
NU21-05- 00681
Czech Ministry of Health
AV21'VP33
Project Strategie Houby Kolem nas i v nas of the Czech Academy of Sciences
NLK
Directory of Open Access Journals
od 2021
PubMed Central
od 2017
ROAD: Directory of Open Access Scholarly Resources
od 2013
- MeSH
- antifungální látky farmakologie MeSH
- Aspergillus * patogenita klasifikace účinky léků genetika MeSH
- aspergilóza * mikrobiologie MeSH
- fylogeneze MeSH
- larva mikrobiologie MeSH
- lidé MeSH
- modely nemocí na zvířatech MeSH
- můry * mikrobiologie MeSH
- virulence MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
UNLABELLED: The Aspergillus genus encompasses a diverse array of species, some of which are opportunistic pathogens. Traditionally, human aspergillosis has primarily been linked to a few Aspergillus species, predominantly A. fumigatus. Changes in epidemiology and advancements in molecular techniques have brought attention to less common and previously unrecognized pathogenic cryptic species. Despite the taxonomic recognition of many cryptic species in section Terrei, their virulence potential and clinical implications, compared to A. terreus sensu stricto, remain poorly understood. Hence, the current study utilized the alternative in vivo model Galleria mellonella to evaluate the virulence potential of 19 accepted Aspergillus species in section Terrei, classified into three series (major phylogenetic clades): Terrei, Nivei, and Ambigui. Analyzing the median survival rates of infected larvae of all species in each series revealed that series Ambigui has a significantly lower virulence compared to series Terrei and Nivei. Taking a closer look at series Terrei and Nivei revealed a trend of survival within each clade, dividing the species into two groups: highly virulent (up to 72 h survival) and less virulent (up to 144 h survival). Histological observation, considering fungal distribution and filamentation, further supported this assessment, revealing increased distribution and hyphal formation in virulent species. Additionally, the susceptibility profile of conventional antifungals was determined, revealing an increased azole minimum inhibitory concentration for some tested cryptic species such as A. niveus and A. iranicus. Our results highlight the importance of cryptic species identification, as they can exhibit different levels of virulence and show reduced antifungal susceptibility. IMPORTANCE: With changing fungal epidemiology and an increasingly vulnerable population, cryptic Aspergillus species are emerging as human pathogens. Their diversity and clinical relevance remain underexplored, with some species showing reduced antifungal susceptibility and higher virulence, highlighting the need for better preparedness in clinical practice. Using the Galleria mellonella model, we assessed the virulence of Aspergillus species of section Terrei, including cryptic and non-cryptic species, across three series Terrei, Nivei, and Ambigui. The results revealed significant virulence variation among the series, with some cryptic species displaying high virulence. Histological analysis confirmed increased hyphal formation and fungal spread in the more virulent species. Additionally, elevated azole minimum inhibitory concentrations were also observed in certain cryptic species. This study presents novel insights into the pathogenicity of Aspergillus section Terrei, emphasizing the critical importance of accurately identifying cryptic species due to their diverse virulence potential and antifungal resistance, which may have substantial clinical implications.
Department of Botany Faculty of Science Charles University Prague Czech Republic
Westerdijk Fungal Biodiversity Institute Utrecht the Netherlands
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015795
- 003
- CZ-PrNML
- 005
- 20250731091233.0
- 007
- ta
- 008
- 250708s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1128/spectrum.02576-24 $2 doi
- 035 __
- $a (PubMed)40094356
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vahedi-Shahandashti, Roya $u Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, ECMM Excellent Center of Mycology, ISHAM Working Group Member of A. terreus, Innsbruck, Austria $1 https://orcid.org/0000000175187795
- 245 10
- $a Deciphering Aspergillus section Terrei in Galleria mellonella model: a clade-specific pathogenicity characterization / $c R. Vahedi-Shahandashti, J. Houbraken, V. Hubka, M. Meijer, BG. Zelger, U. Binder, C. Lass-Flörl
- 520 9_
- $a UNLABELLED: The Aspergillus genus encompasses a diverse array of species, some of which are opportunistic pathogens. Traditionally, human aspergillosis has primarily been linked to a few Aspergillus species, predominantly A. fumigatus. Changes in epidemiology and advancements in molecular techniques have brought attention to less common and previously unrecognized pathogenic cryptic species. Despite the taxonomic recognition of many cryptic species in section Terrei, their virulence potential and clinical implications, compared to A. terreus sensu stricto, remain poorly understood. Hence, the current study utilized the alternative in vivo model Galleria mellonella to evaluate the virulence potential of 19 accepted Aspergillus species in section Terrei, classified into three series (major phylogenetic clades): Terrei, Nivei, and Ambigui. Analyzing the median survival rates of infected larvae of all species in each series revealed that series Ambigui has a significantly lower virulence compared to series Terrei and Nivei. Taking a closer look at series Terrei and Nivei revealed a trend of survival within each clade, dividing the species into two groups: highly virulent (up to 72 h survival) and less virulent (up to 144 h survival). Histological observation, considering fungal distribution and filamentation, further supported this assessment, revealing increased distribution and hyphal formation in virulent species. Additionally, the susceptibility profile of conventional antifungals was determined, revealing an increased azole minimum inhibitory concentration for some tested cryptic species such as A. niveus and A. iranicus. Our results highlight the importance of cryptic species identification, as they can exhibit different levels of virulence and show reduced antifungal susceptibility. IMPORTANCE: With changing fungal epidemiology and an increasingly vulnerable population, cryptic Aspergillus species are emerging as human pathogens. Their diversity and clinical relevance remain underexplored, with some species showing reduced antifungal susceptibility and higher virulence, highlighting the need for better preparedness in clinical practice. Using the Galleria mellonella model, we assessed the virulence of Aspergillus species of section Terrei, including cryptic and non-cryptic species, across three series Terrei, Nivei, and Ambigui. The results revealed significant virulence variation among the series, with some cryptic species displaying high virulence. Histological analysis confirmed increased hyphal formation and fungal spread in the more virulent species. Additionally, elevated azole minimum inhibitory concentrations were also observed in certain cryptic species. This study presents novel insights into the pathogenicity of Aspergillus section Terrei, emphasizing the critical importance of accurately identifying cryptic species due to their diverse virulence potential and antifungal resistance, which may have substantial clinical implications.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a Aspergillus $x patogenita $x klasifikace $x účinky léků $x genetika $7 D001230
- 650 _2
- $a virulence $7 D014774
- 650 12
- $a aspergilóza $x mikrobiologie $7 D001228
- 650 _2
- $a larva $x mikrobiologie $7 D007814
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 12
- $a můry $x mikrobiologie $7 D009036
- 650 _2
- $a fylogeneze $7 D010802
- 650 _2
- $a antifungální látky $x farmakologie $7 D000935
- 650 _2
- $a lidé $7 D006801
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Houbraken, Jos $u Westerdijk Fungal Biodiversity Institute, Utrecht, the Netherlands
- 700 1_
- $a Hubka, Vit $u Department of Botany, Faculty of Science, Charles University, Prague, Czech Republic $u Laboratory of Fungal Genetics and Metabolism, Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000345836496 $7 mzk2016904736
- 700 1_
- $a Meijer, Martin $u Westerdijk Fungal Biodiversity Institute, Utrecht, the Netherlands
- 700 1_
- $a Zelger, Bettina Gudrun $u Institute of Pathology, Neuropathology and Molecular Pathology, Medical University of Innsbruck, Innsbruck, Tyrol, Austria
- 700 1_
- $a Binder, Ulrike $u Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, ECMM Excellent Center of Mycology, ISHAM Working Group Member of A. terreus, Innsbruck, Austria
- 700 1_
- $a Lass-Flörl, Cornelia $u Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, ECMM Excellent Center of Mycology, ISHAM Working Group Member of A. terreus, Innsbruck, Austria $1 https://orcid.org/0000000229467785
- 773 0_
- $w MED00209157 $t Microbiology spectrum $x 2165-0497 $g Roč. 13, č. 5 (2025), s. e0257624
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40094356 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091228 $b ABA008
- 999 __
- $a ok $b bmc $g 2366557 $s 1252920
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 13 $c 5 $d e0257624 $e 20250317 $i 2165-0497 $m Microbiology spectrum $n Microbiol Spectr $x MED00209157
- GRA __
- $a W1253-B24 $p Doctoral Program HOROS
- GRA __
- $a NU21-05- 00681 $p Czech Ministry of Health
- GRA __
- $a AV21'VP33 $p Project Strategie Houby Kolem nas i v nas of the Czech Academy of Sciences
- LZP __
- $a Pubmed-20250708